KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent

Abstract Background KRAS, although a common variant of occurrence (~20% of non‐small‐cell lung carcinoma [NSCLC]) has been untargetable, owing to the molecular structure which inherently prevents drug binding. KRAS mutations in NSCLC are associated with distinct clinical profiles including smokers a...

Full description

Saved in:
Bibliographic Details
Main Authors: Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Amrith BP, Joslia T. Jose, Harkirat Singh, Sakshi Mattoo, Anurag Mehta
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5193
Tags: Add Tag
No Tags, Be the first to tag this record!